Black Communities Have The Most To Lose And Gain With FDA Approval Of New Alzheimer’s Drug
A newly approved drug for treating Alzheimer’s disease received a mixed reception. The Food and Drug Administration granted accelerated approval for Aduhelm on Monday. This is the first new Alzheimer’s drug approved in almost 20 years. Studies show that Black elders are disproportionately more likely much as twice as likely as their white counterparts to…
